Lightcast

Lightcast Discovery is a Cambridge-based biotechnology company developing a next-generation platform for single-cell analysis and manipulation. The company's technology utilizes light-controlled microfluidics to manage picolitre-scale droplets, enabling high-throughput screening and functional assays of individual cells. This platform is designed to accelerate drug discovery, cell line development, and the engineering of complex cell-based therapies. By providing precise control over cell environments and interactions, Lightcast aims to streamline the transition from research to clinical application for biopharmaceutical partners.